SCHEMBL32688401

SCHEMBL32688401

Cc1c(-c2cccc(-c3ccccc3)c2)c(C#N)c(SCc2nnn[nH]2)[nH]c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ CXCR2 P25025 1/20 0.37
▸ TNF P01375 1/20 0.37
▸ PLA2G1B P04054 1/20 0.37
▸ NOD2 Q9HC29 1/20 0.37
▸ NOD1 Q9Y239 1/20 0.37
▸ ATG4B Q9Y4P1 1/20 0.37
▸ HSD11B1 P28845 6/20 0.36
▸ HPGD P15428 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688370 0.91 POLB (0.41) POLBKMT2AMEN1ALDH1A1CXCR2
SCHEMBL32688035 0.90 MEN1 (0.41) POLBKMT2AMEN1CXCR2HSD11B1
SCHEMBL32688298 0.89 POLB (0.37) POLBKMT2AMEN1ALDH1A1CXCR2
SCHEMBL32688295 0.87 CXCR2 (0.36) POLBKMT2AMEN1ALDH1A1NPC1
SCHEMBL32688365 0.85 ALDH1A1 (0.44) POLBKMT2AMEN1ALDH1A1NPC1
SCHEMBL32688125 0.85 ACMSD (0.37) POLBKMT2AMEN1ALDH1A1NPC1
SCHEMBL32688136 0.85 HSD11B1 (0.41) POLBKMT2AMEN1ALDH1A1LMNA
SCHEMBL32688008 0.84 MEN1 (0.42) POLBKMT2AMEN1ALDH1A1CXCR2
SCHEMBL32688292 0.84 HPGD (0.42) KMT2AMEN1ALDH1A1MAPTCXCR2
SCHEMBL32687986 0.82 KMT2A (0.39) POLBKMT2AMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK POLB 508/4885KMT2A 3400/4885MEN1 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback